APA (7th ed.) Citation

Shih-Wei Lai, Shih-Wei Lai, Kuan-Fu Liao, Kuan-Fu Liao, Cheng-Li Lin, Cheng-Li Lin, . . . Hsien-Feng Lin. (2017). Dipeptidyl Peptidase-4 Inhibitors Use and Relative Risk of Ischemic Cerebrovascular Disease in Type 2 Diabetic Patients in a Case-Control Study. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Shih-Wei Lai, Shih-Wei Lai, Kuan-Fu Liao, Kuan-Fu Liao, Cheng-Li Lin, Cheng-Li Lin, Hsien-Feng Lin, and Hsien-Feng Lin. Dipeptidyl Peptidase-4 Inhibitors Use and Relative Risk of Ischemic Cerebrovascular Disease in Type 2 Diabetic Patients in a Case-Control Study. Frontiers Media S.A., 2017.

MLA (9th ed.) Citation

Shih-Wei Lai, et al. Dipeptidyl Peptidase-4 Inhibitors Use and Relative Risk of Ischemic Cerebrovascular Disease in Type 2 Diabetic Patients in a Case-Control Study. Frontiers Media S.A., 2017.